Early-stage life science investors supporting growth-focused companies through sector-specific enterprise investment schemes.
The University of Sheffield spin-out raised a seven-figure sum from a syndicate to develop quantum-secure networking.
"The single photon source developed by Aegiq represents a platform technology with unparalleled specifications that enables various applications. As a photonics guy, I am more than thrilled to invest here and support the highly skilled team on their journey,"
The investment was led by BGF and Parkwalk to support pre-clinical work, clinical trials, and regulatory approval.
"There are over three million dialysis patients worldwide and every year patients undergo nearly 650,000 surgical AVF creation procedures. However, these procedures take a long time to heal and are prone to failure. Our technology has the power to significantly improve the outcomes for dialysis patients, improving their quality of life and saving millions of pounds in the process. We are delighted to have the support of BGF and Parkwalk to help the business move forward with our clinical trials and ultimately roll-out this ground-breaking product to a global market."
Deepbridge Capital backed the seed round to support the commercialisation of advanced space propulsion systems.
"We have been delighted with our progress to date and the significant interest in our technologies from major players in our sector. This next stage of development will see the Company expand on these exciting relationships whilst continuing our product development."
The oversubscribed raise was led by investment platform Wealth Club alongside existing backers Deepbridge Capital and Boundary Capital.
"Glyconics offers a transformational, cost-efficient, rapid and non-invasive approach to diabetes screening – and it is testament to this pioneering device and all at Team Glyconics that this raise was so significantly over-subscribed. We are delighted to be continuing with our existing investors and, of course, welcome our new investors from Wealth Club and other private investors to the fold."
Deepbridge Capital led the £2m investment to help the event tech scale-up accelerate out of the pandemic and expand into the USA.
"We are very focused on ensuring our software helps both our corporate clients and our host venues create greater efficiencies within the increasingly complex event booking process. This is why, during the pandemic, we beat traditional agency incumbents to win significant multi-year contracts from FTSE 100 companies in the media, professional services and FMCG sectors."
